{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Ulcerative+Colitis+Acute", "query": { "condition": "Ulcerative Colitis Acute" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Ulcerative+Colitis+Acute&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T08:21:42.359Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT05867329", "title": "Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ulcerative Colitis Acute" ], "interventions": [ { "name": "Cyclosporine Injection (IV)", "type": "DRUG" }, { "name": "Cyclosporine Oral Product", "type": "DRUG" }, { "name": "Upadacitinib Extended Release Oral Tablet", "type": "DRUG" }, { "name": "Intravenous Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone Oral Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Berinstein, Jeffrey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 162, "start_date": "2023-09-30", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2025-04-15", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05867329" }, { "nct_id": "NCT02093663", "title": "Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "MMX Mesalamine/Mesalazine (Low Dose)", "type": "DRUG" }, { "name": "MMX Mesalamine/Mesalazine (High Dose)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 107, "start_date": "2014-12-12", "completion_date": "2018-11-28", "has_results": true, "last_update_posted_date": "2021-06-09", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 9, "location_summary": "Baltimore, Maryland • Boston, Massachusetts • Newton, Massachusetts + 5 more", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Newton", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02093663" }, { "nct_id": "NCT07258771", "title": "Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ulcerative Colitis Acute" ], "interventions": [ { "name": "Oral Upadacitinib", "type": "DRUG" }, { "name": "Intravenous Methylprednisolone", "type": "DRUG" }, { "name": "Oral Upadacitinib Placebo", "type": "DRUG" }, { "name": "Oral prednisolone Taper", "type": "DRUG" }, { "name": "Oral Prednisone - Hospital Dose Steroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Berinstein, Jeffrey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 110, "start_date": "2026-01-16", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07258771" }, { "nct_id": "NCT01476995", "title": "Prognostic Indicators as Provided by the EPIC ClearView", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Congestive Heart Failure", "Valvular Heart Disease", "Atrial Fibrillation", "Hypertension", "Pyelonephritis", "Acute Renal Failure", "Renal Failure", "Viral Hepatitis", "Alcoholic Hepatitis", "Steatohepatitis", "Cirrhosis", "Asthma", "COPD", "Bronchitis", "Emphysema", "Pneumonia", "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis", "Diverticulitis", "Peptic Ulcer Disease", "Irritable Bowel Syndrome", "Cholecystitis", "Pancreatitis", "Malabsorption Disorders", "Celiac Sprue", "Diabetes" ], "interventions": [], "intervention_types": [], "sponsor": "Epic Research & Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 353, "start_date": "2010-09", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2011-11-22", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01476995" }, { "nct_id": "NCT00350415", "title": "A Double Blind Study for the Treatment of Acute Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Mesalamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Warner Chilcott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 772, "start_date": "2006-06", "completion_date": "2007-05", "has_results": false, "last_update_posted_date": "2013-04-17", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 78, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Tucson, Arizona + 74 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00350415" }, { "nct_id": "NCT05252273", "title": "Assessment of Patients With Acute Pouchitis Treated With Antibiotics", "overall_status": "SUSPENDED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pouchitis", "Ulcerative Colitis" ], "interventions": [ { "name": "Observational, No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Alimentiv Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2021-12-07", "completion_date": "2024-12-09", "has_results": false, "last_update_posted_date": "2024-02-20", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 2, "location_summary": "New York, New York • Cleveland, Ohio", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05252273" }, { "nct_id": "NCT07502339", "title": "Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "UC - Ulcerative Colitis" ], "interventions": [ { "name": "Upadacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 50, "start_date": "2026-07-01", "completion_date": "2028-08-01", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07502339" }, { "nct_id": "NCT06420492", "title": "Study of Novel Therapeutics for Acute Remedy of Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis", "Ulcerative Colitis Chronic Moderate", "Ulcerative Colitis Chronic Severe" ], "interventions": [ { "name": "BRS201", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2025-09-30", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 1, "location_summary": "Chestnut Hill, Massachusetts", "locations": [ { "city": "Chestnut Hill", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06420492" }, { "nct_id": "NCT00385736", "title": "Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "adalimumab", "type": "BIOLOGICAL" }, { "name": "placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 576, "start_date": "2006-11", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2011-04-11", "last_synced_at": "2026-05-22T08:21:42.359Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Fayetteville, Arkansas + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00385736" } ] }